Abstract
Dietary fat and the risk of prostate cancer: Prostate cancer has emerged as the most frequently diagnosed malignancy among men in the United States, taking thousands of lives every year (1). It is a multistep disease. In the United States, while there are more than 15 million men with localized prostate cancer, only 40–50,000 men will develop malignancy and die in a given year. Thus the development of the metastatic phenotype is an important rate limiting step in the natural history of prostate cancer. Through the incidence of the latent form of the diseases the same worldwide, there is significant geographic variation in the diagnosis of clinically evidence prostate cancer and mortality (2–4) suggesting involvement of environmental factors in this process. Moreover, people who migrate from low-incidence countries to high-incidence countries show increased risk of invasive prostate cancer (5–8) indicating a positive role for lifestyle factors, such as diet and nutrition.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Parker, S.L., Tong, T., Bolden, S., and Wingo, P.A. Cancer Statistics, 1997. CA Cancer J. Clin. 47:5–27 (1997).
Jackson, M.A., Ahluwalia, B.S., Herson, J., et al. Characterization of prostatic carcinoma among blacks: a continuation report. Cancer Treat. Rep. 61:167–172 (1977).
Brelow, N.E., Chan, C.W., Dhom, G., et al. Latent carcinoma of prostate at autopsy in seven areas. Int. J. Cancer 20:680–688 (1977).
Yatani, R., Chigusa, I., Akazaki, K., Stemmerman, G.N., Welsh, R.A., and Correa P. Geographic pathology of latent prostatic cancer. Int. J. çancer 29:611–616 (1982).
Haenszel, W., and Kurihara, M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J. Nat. Cancer Inst. 40:43–68 (1968).
Shimizu, H., Ross, R.K., Bernstein, L., Yatani, R., Henderson, B.E. and Mack, T.M. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br. J. Cancer 63:963–966 (1991).
Muir, C.S., Nectoux, J., and Straszewski, J. The epidemiology of prostatic cancer: geographical disribution and time-trends. Acta Oncol. 30:133–140 (1991).
Yu, H., Harris, R.E., Gao, Y.T., Gao, R., and Wynder, E.L. Comparative epidemiology of cacers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int. J. Epidemiol. 20:76–81 (1991).
Whittemore, A.S., Kolonel, L.N., Wu, A.H., John, E.M. Gallagher, R.P., Howe, G.W., Burch, J.D., Hankin, J., Dreon, D.M., West, D.W., Tehm C., and Paffenbarger, R.S. Prostate cancer in relation to diet, physical activity and body size, in blacks, white and asians in the U.S. and Canada. J. Natl. Cancer Inst. 87:652–661 (1995).
Mettlin, C., Selenskas, S., Natarajan, N., and Huben, R. Beta-carotene and animal fats and their relationship to prostate cancer risk. Cancer 64:605–612 (1995).
Giovannucci, E., Rimm, E.B., Colditz, G.A., Stampfer, M.J., Ascherio, A., Chute, C.C., and Wilett, W.C. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst. 85:1571–1579 (1993).
Le Marchand, L., Kolonel, L.N., Wilkins, L.N., Myers, B.C., and Hirohata, T. Animal fat consumption and cancer of the prostate: a prospective study in Hawaii. Epidemiology 5:276–282 (1994).
Gann, P.H., Hennekens, C.H., Sacks, F.M., Grodstein, F., Giovannucci, E., and Stampfer, M.J. Prospective study of plasma fatty acids and risk of prostate cancer. J. Natl. Cancer Inst. 86:281–286 (1993).
Wang, Y., Corr, J.G., Thaler, H.T., Tao, Y., Fair, W.R., and Heston, W.D. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J. Natl. Cancer Inst. 87:1456–1462 (1995).
Chaudry, A.A., Wahle, K.W., McClinton, S. and Moffat, L.E. Arachidonic acid meabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors. Int. J. Cancer 57:176–180 (1994).
Dahiya, R., Yoon, W.H., Boyle, B., Schoenberg, S., Yen, t.B. and Narayan, P. biochemical, cytogenetic and morphological characteristics of human primary and metastatic prostate cancer cell lines. Biochem. Int. 27:567–577 (1992).
Anderson, K.M., Wygodny, J.B., Ondrey, F., and Harris J. Human PC3 prostate cell line DNA synthesis is suppressed by eicosatetraynoic acid, an in vitro inhibitor of arachidonic acid metabolism. Prostate 12:3–12, (1988).
Ghosh, J. and Myers, C.E. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem. biophys. Res. Commun. 235:418–423 (1995).
Khan, W.A., Blobe, G.C., and Hannun, Y.A. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cell. Signaling 7:171–184 (1995).
Schachter, J.B., Lester, D.S., and Alkon, D.L. Synergistic activation of protein kinase C by arachidonic acid and diacyglycerols in vitro: generation of a stable membrane-bound, cofactor-independent state of protein kinase c activity. Biochim. Biophys. Acta. 1291: 167–176 (1996).
Han, J., McCormick, F., and Macara, I.G. Regulation of rasGAP and the neurofibromatosis-1 gene product by eicosanoids. Science 252:576–579 (1991).
Needleman, P., Turk, J., Jakschik, B.A., Morrison, A.R., and Lefkowith, J.B. Arachidonic acid metabolism. Ann. Rev. Biochem. 55:69–102 (1986).
Samuelsson, B., Dahlen, S.E., Lindgren, J.A., Rouzer, C.A., and Serhan, S.N. Leukotrienes and lipoxins: structures, biosynthesis and biological effects. Science 237:1171–1176 (1987).
Ara, G., and Teicher, B.A. Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Prostaglandins, Leukotrienes and Essential Fatty Acids 54:3–16 (1996).
Young, M.R. Eicosanoids and he immunology of cancer. Cancer Mets. Rev. 13:337–348 (1994).
Nolan, R.D., Danilowicz, R.M., and Eling, T.E. Role of arachidonic acid metabolism in the mitogenic reponse of BALB/c 3T3 fibroblasts to epidermal growth factor. Mol. Pharmacol. 33:650–656 (1988).
Eling, T.E. and Glasgow, W.C. Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating epidermal growth factor-dependent mitogenesis. Cancer Met. Rev. 13:397–410 (1994).
Steller, H. Mechanisms and genes of cellular suicide. Science (Washington, DC) 267:1445–1449 (1995).
Lim, H., Paria, B.C., Das, S.K., Dinchuk, J.E., Langenbach, R., Trzaskos, J.M., and Dey, S.K. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91:197–208 (1997).
Goetzel, E.J., An, S., and Zheng, L. Specific suppression of prostaglandin E2 of activation-induced apoptosis of human CD4+8+ T lymphoblasts. J. Immunol. 154:1041–1047 (1995).
Jaattela, M., Benedict, M., Teweri, M., Shayman, J.A., and Dixit, V.M. Bcl-x and Bcl-2 inhibit TNF and FAS-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10:2297–2305 (1995).
O’Donnell, V.B., Spycher, S., and Azzi, A. Involvement of oxidents and oxident-generating enzyme(s) in tumor-necrosis-factor-alpha-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem. J. 310:133–141 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ghosh, J., Myers, C.E. (1999). Central Role of Arachidonate 5-Lipoxygenase in the Regulation of Cell Growth and Apoptosis in Human Prostate Cancer Cells. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_84
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4793-8_84
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7171-7
Online ISBN: 978-1-4615-4793-8
eBook Packages: Springer Book Archive